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Background/aim: The purpose of this retrospective study was to determine the effectiveness of oral iron therapy in breath-holding
spells and evaluation of electrocardiographical changes.
Materials and methods: Three hundred twelve children aged 1–48 months and diagnosed with breath-holding spells between January
2017 and April 2018 were included. Patients’ laboratory findings were compared with 100 patients who had one simple febrile seizure.
Results: Cyanotic breath-holding spells were diagnosed in 85.3% (n = 266) of patients, pallid spells in 5.1% (n = 16), and mixed-type spells in
9.6% (n = 30). Sleep electroencephalograms were applied for all patients, 98.2% (n = 306) of which were normal, while slow background rhythm
was determined in 1.2% (n = 4). Epileptic activity was observed in only 2 patients (0.6%). The mean hemoglobin (Hb) value in the breathholding spell group was 10.1 mg/dL. Patients’ mean corpuscular volume (MCV) was 73 fL. Patients’ Hb and MCV values were statistically
significantly lower than those of the control group (P < 0.001). The difference between spell burden was not statistically significant (P = 0.691).
Spell burden decreased equally in both groups.
Conclusion: Oral iron therapy can be administered in breath-holding seizures irrespective of whether or not the patient is anemic.
Key words: Breath-holding spell, iron deficiency, electroencephalography

1. Introduction
Breath-holding spells are a nonepileptic paroxysmal
phenomenon frequently seen in childhood. They were
first reported as ‘voluntary breath holding’ in 1737 by
Nicholas Culpepper and were described as “A disease
... in children from anger or grief, when the spirits are
much stirred and run from the heart to the diaphragms
forcibly and hinder or stop the breath ... but when
the passion ceaseth” (1). The reported prevalence in
European countries is 3.6%–4.6% (2,3). There are three
types: cyanotic, pallid, and mixed type. Pallor resulting
from bradycardia and asystole developing secondary to
increased vagal tone is seen in pallid seizures. While no
change in heart beat occurs in cyanotic breath-holding
seizures, a blue color is observed around the mouth and
in the face associated with prolonged expiration and a
decrease in oxygen saturation. The majority of spells
conclude with a deep inspiration, although they may
sometimes progress with myoclonic jerks or generalized
tonic-clonic seizures (4). Seizures are frequently seen
between 6 months and 4 years. Spells occur in association
with an emotional or physical stimulus and do not occur
during sleep. A good history and physical examination

are important in differentiating breath-holding seizures
from epileptic seizures and other causes of syncope.
Prognosis is benign, and attacks decline with maturation
of the autonomic nervous system. Loss of consciousness
and seizure-like tonic posture may develop not only in
pallid spells but also in prolonged cyanotics. An attack
being observed by an experienced specialist is diagnostic.
Electroencephalography (EEG) is performed to exclude
tonic seizures capable of causing similar findings, and
electrocardiography (ECG) is applied to exclude familial
cardiac arrhythmias in most centers. Neurological
examination is generally normal, while iron deficiency
anemia is often present in laboratory tests.
Iron deficiency affects billions of people worldwide
and consists of a three-step process that affects the entire
body. Iron stocks are reduced in the first phase and then
iron-deficient erythropoiesis follows, ultimately resulting
in iron deficiency anemia, which is characterized by
decreased hemoglobin (Hb), red blood cell count, and
mean corpuscular volume (MCV) (5). Iron deficiency
anemia is a nutritional disorder that impairs children’s
growth, development, and immune system and leads to
pallor and fatigue.

* Correspondence: drgurkangurbuz@hotmail.com

230

This work is licensed under a Creative Commons Attribution 4.0 International License.

GÜRBÜZ et al. / Turk J Med Sci
In childhood, due to high growth rates, iron
requirements are increased. Inadequate consumption of
iron-containing foods or excessive intake of cow or goat
milk, especially in the first 6 months of life, increases the
risk of iron deficiency (6).
Iron is essential not only for erythropoiesis but also for
cerebral neurotransmission. That may be the reason why
febrile seizures and breath-holding spells are much more
common in individuals who have iron deficiency (7). For
this reason, iron stocks should be evaluated and oral iron
therapy should be given in breath-holding spells, even if
the patient does not have anemia.
Patients with breath-holding spells have been observed
to benefit from oral iron therapy. Piracetam is another
option in patients who fail to benefit from iron therapy.
Basic principles of treatment include explaining to families
that breath-holding spells are a treatable disease and have
a good course, and emphasizing the behavior required at
the time of attacks.
The purpose of this retrospective study was to determine
the effectiveness of oral iron therapy in breath-holding
spells and evaluate electrocardiographical changes.
2. Materials and methods
In this retrospective study, children aged 1–48 months
who administered to our hospital’s pediatric neurology
outpatient clinic were included. A total of 350 patients
having breath-holding spells were diagnosed out of 25,740
between January 2017 and April 2018. Our patients’
histories and examination findings, laboratory tests,
and EEG and ECG results were obtained from patient
records. Patients with known cardiac, hematological, or
neurological problems and those failing to attend followup appointments or who could not be contacted by
telephone were excluded.
The spells were classified into cyanotic, pallid, or mixed
types according to the skin color change during episodes.
Severity of spells was divided into two groups of simple
and complicated. Both types start with an emotional
or painful experience; the simple type ends with a deep
breath and cry while complicated spells generally end with
loss of consciousness and seizure-like tonic posture.
All patients were evaluated in terms of age, sex,
age at onset of attacks, attack frequency, type of breathholding spell, delivery history, developmental milestones,
laboratory values, EEG, ECG, and presence of epileptic
seizures, febrile seizures, or breath-holding spells in firstdegree relatives.
Laboratory values of 100 age- and sex-matched patients
under monitoring at the same center and undergoing
febrile convulsions were randomly included as the control
group whether they had anemia or not. Blood was not
collected again from these patients, and their laboratory
results were also investigated retrospectively.

Hb, serum iron, serum ferritin, and total iron-binding
capacity were examined in basal laboratory tests performed
at the time of initial presentation in order to examine the
relationship between iron deficiency anemia and breathholding spells.
Patients with HB, hematocrit, and MCV levels lower
than the limits of age and ferritin values less than 15 mg/
dL were diagnosed as having iron deficiency anemia. Oral
elemental iron treatment was started at 4 mg/kg per dose
in all cases.
Echocardiography and electrocardiography were
evaluated by the cardiology department for the exclusion
of cardiac pathologies. The QT interval was calculated
in terms of long QT syndrome using Bazett’s formula.
Electroencephalographic evaluation was performed
by our hospital’s pediatric neurology specialists. EEG
findings were examined within three groups, 1- normal,
2- slow waves and background rhythm abnormality, and
3- epileptic anomalies.
Patients were called for follow-up appointments
3 months after the initiation of treatment and their
hematological parameters were evaluated again. Thirtyeight of the patients were excluded from the study due to
failure to complete tests or attend follow-ups.
2.1. Statistical analysis
SPSS 24.0 (IBM Corp., Armonk, NY, USA) and PAST
3 (https://folk.uio.no/ohammer/past/) software were
used for variable analysis. Normality of distribution was
evaluated using the Shapiro–Wilk test for single-variable
data and Mardia’s test (Dornik and Hansen omnibus)
for multivariable data, while variance homogeneity was
assessed with the Levene test. The Mann–Whitney U
test and Monte Carlo results were used together in the
comparison of quantitative data from two independent
groups. The Kruskal–Wallis H test and Monte Carlo results
were used together in the comparison of quantitative data
from more than two independent groups. The Wilcoxon
signed ranks test and Monte Carlo results were used in the
comparison of two repeated measurements from dependent
quantitative variables. The marginal homogeneity test
was used with the Monte Carlo simulation technique.
Quantitative variables were expressed as mean ± standard
deviation (SD), median ± interquartile range (IQR), and
median range (maximum–minimum), while categorical
variables were expressed as n (%). Variables were analyzed
at a 95% confidence level, and P-values less than 0.05 were
regarded as statistically significant.
3. Results
Cyanotic breath-holding spells were diagnosed in 85.3%
(n = 266) of patients, pallid spells in 5.1% (n = 16), and
mixed-type spells in 9.6% (n = 30). These patients’
laboratory findings and demographic data were compared
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with those of 100 patients undergoing simple febrile
convulsions (Table 1).
Onset of spells occurred below 24 months in the great
majority of cases (64.7% [n = 202]). This group’s mean Hb
concentration was 9.8 mg/dL (P = 0.045). Breath-holding
spells beginning to be observed after the age of 6 months
suggested an association with inadequate iron support in
the 4th month, when childhood physiological anemia is
seen.
Patient and control group Hb and MCV values are
shown in Table 2. The mean Hb value in the patient group
was 10.1 mg/dL. When subjects were considered in terms
of appropriateness for age, Hb values were below –2 SDs in
82.4% (n = 257) of patients. Patients’ mean MCV value was
73 fL. Patient group Hb and MCV values were significantly
lower compared with those of the control group (P <
0.001). In the patient group 55 patients had no anemia.
Twenty-eight patients had Hb levels below 7 mg/dL and 68
patients had MCV below 70 fL (Table 3).
Seventy-seven patients’ spells were longer than 30 s,
50 of them were described as complicated type, and this
group’s median Hb value was 9.1 mg/dL. Median Hb value
of the patients who had spells less than 30 s was 11 mg/
dL (P = 0.032) (Table 3). Sleep EEG was performed for
all patients and results were normal in 98.2% (n = 306) of
patients, while slow background rhythm was determined
in 1.2% (n = 4). Epileptic activity was observed in only
2 (0.6%) patients. Both epileptic activity and breathholding spells were observed in one of these, and the
patient was started on oral iron and antiepileptic therapy.
No pathology was determined in these patients during
cranial magnetic resonance imaging (MRI) performed to

determine epileptic focus. The patients’ breath-holding
spells resolved with iron therapy. The other patient is still
being monitored without antiepileptic therapy.
ECG and echocardiography were performed for all
patients. QTc values were not above normal in any patients.
The patients’ mean QTc value was 409.64 ms. Significant
prolongation was determined in QTc values in subjects
with complicated breath-holding spells compared to those
with the simple type (P = 0.003) (Table 3). Pathology was
determined in echocardiography in 21 (6.8%) patients,
consisting of patent foramen ovale in 15 (4.8%), secundum
atrial septal defect in 3 (1%), and ventricular septal
defect in 3 (1%). The patients with pathology identified
in echocardiography continue to be monitored by the
cardiology and pediatric neurology departments.
All the patients included in the study received 4 mg/
kg oral iron therapy daily. However, since 20 patients
exhibited no response to iron therapy, piracetam therapy
was added at the end of the third month. When the
patients’ spell burden and duration were compared before
and after treatment, it was observed that pretreatment
spell burden decreased from 10 spells/month to 2 and
the duration of spells decreased from 15 s to 5 s (Tables
4 and 5). Statistically significant decreases were observed
after treatment in attack numbers and durations (P < 0.001
for both). Patients in the breath-holding spell group were
compared among those with and without anemia. There
was no significant difference between the two groups’
spell burden after iron treatment (P = 0.691). Spell burden
decreased equally in both groups.
Fifty-seven (18.2) patients still had anemia after 3
months with iron supplementation.

Table 1. Demographic data of breath-holding spell and control groups.

Age
Sex
Anemia
Anemia after iron treatment
Developmental delay
Perinatal problems
Consanguinity
Epilepsy in first-degree relatives
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<24 months
>24 months
Female
Male
Absent
Present
Absent
Present
Absent
Present
Absent
Present
Absent
Present
Absent
Present

Breath-holding
spells, n (%)

Control,
n (%)

202 (64.7)
110 (35.3)
132 (42.3)
180 (57.7)
55 (17.6)
257 (82.4)
255 (81.8)
57 (18.2)
306 (98.1)
6 (1.9)
303 (97.1)
9 (2.9)
159 (51)
153 (49)
288 (92.3)
24 (7.7)

70 (70)
30 (70)
42 (42)
58 (58)
71 (71)
29 (29)
100 (100)
0 (0)
96 (4)
6 (6)
57 (57)
43 (43)
89 (89)
11 (11)

P-value
0.480
0.1
<0.001

0.343
0.526
0.303
0.306
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Table 2. Demographic data and laboratory values of breath-holding spell group.
n (%)

Mean ±SD

Median (max/min)

Ferritin

312

20.38±9.60

20 (52/4)

QTc

312

409.64±29.37

421 (449/350)

Month of onset of spells

312

9.44±3.58

9 (20/2)

Pretreatment spell burden

312

20.56±24.73

10 (100/1)

Posttreatment spell burden

312

3.97±1.98

2 (30/0)

Difference of spell burden between
pre- and posttreatment

312

16.58±3.58

10 (99/-8)

Pretreatment spell duration (s)

312

28.56±7.93

15 (120/5)

Posttreatment spell duration (s)

312

5.80±1.79

5 (45/0)

Difference of spell duration between
pre- and posttreatment (s)

312

-22.76±8.11

–10 (10/–120)

Type of breath holding spell

Cyanotic
Pallid
Mixed

266 (85.3)
16 (5.1)
30 (9.6)

Type of breath holding spell-2

Complicated
Simple

77 (24.7)
235 (75.3)

Response to treatment

Complete response
>%50 decrease
<%50 decrease
No response

147 (47.1)
122 (39.1)
23 (7.4)
20 (6.4)

BHS in first-degree relatives

Present
Absent

44 (14.1)
268 (85.9)

History of seizure

Present
Absent

10 (3.2)
302 (96.8)

Electroencephalography

Normal
Slow waves
Epileptic activity

306 (98.2)
4 (1.2)
2 (0.6)

Normal
PFO
VSD
ASD

291 (93.3)
15 (4.8)
3 (1)
3 (1)

Echocardiography

SD: Standard deviation, Max: maximum Min: minimum, MCV: mean corpuscular volume, BHS: breath holding spell, PFO: patent
foramen ovale, PDA: patent ductus arteriosus, VSD: ventricular septal defect, ASD: atrial septal defect.

4. Discussion
This study investigated the laboratory findings of patients
diagnosed with breath-holding spells and short-term
response to iron supplementation. Breath-holding spells
are a nonepileptic paroxysmal phenomenon frequently
seen in childhood, particularly at 6–48 months. Although
the condition is a source of anxiety for families, it is
frequently described as benign. The earliest age at onset
was reported in a 3-day-old newborn with a family history
(4). The youngest patient in our study was aged 2 months.

No statistically significant difference was determined in
terms of sex in our study. Mean age at presentation was
10.3 months, and mean age at onset of symptoms was
9.4 months. In agreement with our findings, the great
majority of patients in previous studies have been under 1
year of age. The fact that breath-holding spells frequently
commence after 6 months suggests a possible association
with insufficient iron support at 4 months, when childhood
physiological anemia is seen, and problems regarding the
transition to supplementary foods.
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Table 3. Comparison of hemoglobin, mean corpuscular volume, ferritin, QTc, and anemia and iron deficiency presence in terms of
breath-holding spell type, spell burden, and duration.
Breath-holding
spell type (n=312)
Complicated

P-value

Simple

Spell burden
(per month)
>10

Median ± IQR

P-value

<10

Spell duration (s)
>30

Median ± IQR

P-value

<30

Median ± IQR

Hemoglobin
(mg/dL)

10.2 ± 1.7

10.1 ± 1

0.833

9.2 ± 1

11.4 ± 1

0.042

9.1 ± 1

11 ± 1.2

0.032

Mean corpuscular
volume (fL)

72 ± 8

73 ± 6

0.286

65 ± 3

74 ± 4

0.038

64 ± 4

75 ± 4

0.040

Ferritin (g/L)

20 ± 11

20 ± 11

0.517

11 ± 2

31 ± 4

0.002

10.2 ± 1

33 ± 2

0.001

QTc (ms)

421 ± 50

389 ± 39

0.003

412 ± 32

398 ± 42

0.567

405 ± 23

412 ± 12

0.65

P-value

Spell burden
(per month)

P-value

Spell duration (s)

Breath-holding spell type
Complicated

Simple

Anemia +
(n = 257)

77

180

Iron deficiency +
(n = 287)

77

210

>10

<10

0.076

92

135

0.089

149

138

P-value

>30

<30

0.082

35

222

0.065

0.380

192

95

0.780

Table 4. Alteration of spell count and duration before and after iron treatment.
Breath-holding
spell (n=312)

Pretreatment

Posttreatment

P-value

Median ± IQR
Spell burden

10 ± 15

2±6

<0.001

Spell duration (s)

15 ± 35

5 ± 10

<0.001

n (%)
Spell burden
>30 spells/month

27 (8.7)

0 (0)

10–30 spells/month

122 (39.1)

51 (16.3)

<10 spells/month

163 (52.2)

261 (83.7)

Epilepsy was present in first-degree relatives in 7.7%
(n = 24) of patients. This figure was markedly lower than
in other studies (8). This suggests that breath-holding
seizures may have been misdiagnosed as epilepsy. Studies
have stated that breath-holding spells are inherited in an
autosomal dominant manner (8–10). In our study, breathholding spells were present in 14.1% (n = 44) of firstdegree relatives of our patients.
The proportion of cyanotic breath-holding spells in
previous studies ranges between 58% and 86.1%, and these
seizures were also predominant in our study, at 85.3% (n =
266) (2,11,12). This predominance may be due to cyanosis

234

<0.001

causing greater alarm among families and leading them to
feel that ‘the child is about to die’, thus resulting in higher
numbers of hospital presentations. Spell burden ranges
from ‘a few times every day’ to ‘one attack in a lifetime’.
Spell durations in the literature range between 40 and 60 s,
the mean duration in our study being 28.56 s. Spell burden
and durations both decreased with oral iron therapy.
Iron deficiency has long been known to represent a
risk factor for breath-holding spells (13). Iron deficiency
anemia was determined in 82.4% (n = 257) of our patients.
Lower prevalences of 47.9%–73% have been reported in
other studies (14,15). The higher rate in our study may
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Table 5. Alteration of hematological parameters, spell burden, and duration in breath-holding spell group before and after iron
treatment in terms of anemia.
Breath-holding spell group
Anemia (-) n = 55

Anemia (+) n = 257

P-value

Mean (±SD)

Mean (±SD)

Hemoglobin (mg/dL)

12.7 (±4)

9.1(±2)

<7

0

27

>7

55

230

Hematocrit

38 (±4)

29 (±5)

<0.001

Mean corpuscular volume (fL)

81 (±12)

69 (±14)

0.045

<70

0

68

>70

55

189

Ferritin (g/L)

22 (±6)

9 (±2)

<0.001

Iron (μg/dL)

38 (±14)

27 (±9)

0.098

Total iron-binding capacity

360 (±50)

389 (±59)

0.567

0.03

Median ± IQR

Median ± IQR

QTc (ms)

425 ± 54

421 ± 44

0.060

Onset of spells (month)

9±6

9±5

0.744

Pretreatment spell burden

2±5

2 ± 10

<0.001

Posttreatment spell burden

2 ± 10

2±5

0.908

Difference of pre- and posttreatment spell burden

10 ± 20

10 ± 16

0.691

Pretreatment spell duration (s)

5 ± 10

10 ± 16

<0.001

Posttreatment spell duration (s)

2±5

5 ± 10

0.038

Difference of pre- and posttreatment spell duration (s)

–9.5 ± 15

–11.3 ± 35

0.049

derive from our hospital being in a province of Turkey
with a low socioeconomic level. Anemia is thought to
represent the principal cause of decreased cerebral blood
flow. Iron is also known to be involved in catecholamine
metabolism, and changes occur in neurotransmission in
the central nervous system in the event of iron deficiency
(16). Clinical and laboratory findings have been reported
to be potentially associated with cerebral erythropoietin,
nitric oxide, and interleukin-1 levels (16,17). Additionally,
animal experiments showed changes in cerebral dopamine
metabolism in individuals with iron deficiency (18,19).
EEGs of children with iron deficiency had slower activity
than those of the control group, which could be associated
with central nervous system dysfunction (20). Besides
this, febrile convulsions were more frequent in patients
with iron deficiency (21). In light of all this information,
it can be beneficial to administer iron therapy in reducing
seizure burden regardless of anemia in breath holding
spells.

Lombrosso and Lerman also stated that iron
deficiency is not the sole cause of breath-holding spells,
and that iron deficiency also exacerbates the underlying
pathology (22). In our study, all patients, regardless of
anemia, were therefore started on 4 mg/kg oral elemental
iron supplement daily, based on the information in the
previous literature. After 3 months, seizure frequency had
decreased by 50% or more in 86.2% of patients. Previous
studies have reported response rates to iron therapy of
66.6%–96%, and our finding is in agreement with these
(8,14,15). Interestingly, comparison of responses to iron
therapy among patients with and without anemia revealed
that both spell burden and spell duration decreased in
both groups, although these results were not statistically
significant. This shows that iron therapy can be effective in
breath-holding spells even if the patient is not anemic. In
their controlled study of 67 patients with breath-holding
spells, Daoud et al. reported that subjects with iron
deficiency benefitted more from iron therapy then those
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without (23). To the best of our knowledge, no previous
studies have compared breath-holding spells in patients
with and without anemia.
Many breath-holding spells may be misdiagnosed as
epileptic seizures, due to both a lack of knowledge and
the fact that the attack is not observed by a health worker,
and patients may be incorrectly started on antiepileptic
therapy. The two conditions can be easily differentiated
by means of history. EEG is frequently used to distinguish
epileptic seizures from breath-holding spells. EEG was
performed for our entire patient group, and epileptic
activity was determined in only 0.6% (n = 2). No pathology
was determined in MRI preformed due to epileptic focus
being observed in these two patients. Comorbid epileptic
seizures and breath-holding spells were determined in
one case, and this patient was started on phenobarbital
in addition to iron therapy. Although pathology was
determined in EEG in the other case, that patient was
not started on antiepileptic therapy since the history was
compatible with breath-holding spells. The patients’ spells
resolved entirely with iron therapy. EEG is impracticable
in the diagnosis of breath-holding spells, since it is difficult
to perform with children and requires sedation, and also
since it is not more useful than history-taking.
Arrhythmias and particularly long QT syndrome
are useful in the differential diagnosis of breath-holding
spells. Autonomic nervous system dysfunction leading to
QT prolongation at the time of attack has been implicated,
particularly in pallid breath-holding spells (24). This QT
prolongation can lead to fatal arrhythmias and sudden
cardiac arrest in cases with familial long QT syndrome.
ECG and echocardiography were therefore performed in
all cases. No long QT syndrome was determined in any
patient. Although the absence of rhythm abnormality in any
out of 312 patients might at first sight appear insignificant,
preventing the sudden death of a child with a simple
test is of great importance. The presence of severe, lifethreatening arrhythmias, such as Wolf–Parkinson–White

and long QT syndrome, has also been shown in previous
studies, as in the nonarrhythmia group (25). In a cardiac
repolarization study performed with “event recorders”
in breath-holding spells, autonomic dysregulation was
observed in patients compared to the control group. It
was argued that iron deficiency may have had an effect on
this autonomic change (26). It was reported that patients
with prolonged and frequent spells had longer QT and
T-wave dispersion than the control group (27). Akalın et
al. compared 43 patients with breath-holding spells and 25
healthy children and determined statistically significantly
longer QT and QTc dispersion in the patient group than
in the controls. This also shows an autonomic effect and
arrhythmogenic potential in breath-holding spells (28).
Pathology was determined in echocardiography in 6.8%
(n = 21) of patients, and these were also not pathologies
that could be linked to breath-holding spells.
As explained above, EEG, ECG, and echocardiography
are not diagnostic in breath-holding spells. However, a
good history is diagnostic. Asking the mother questions
such as ‘Do the attacks always occur following an
emotional stimulus or trauma?’ and ‘Do they occur during
sleep?’ is to a large extent diagnostic of breath-holding
spells. As also described, breath-holding spells frequently
occur after an emotional and traumatic event, but never in
sleep. History is therefore the gold standard. Studies have
shown that piracetam therapy can be useful if no benefit is
achieved with oral iron therapy in the first instance (29).
Giving the family appropriate information is also of great
importance in addition to medical treatment.
In conclusion, breath-holding spells can be diagnosed
with an accurate history. EEG and echocardiography are
of no diagnostic value. ECG, which is cost-effective and
can be easily performed in any center, is important in
terms of preventing rare fatal complications. Iron therapy
should be given in all breath-holding spells, regardless of
anemia, because it is much more related with iron stocks
than hemoglobin.
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